Cargando…

Responses of metastatic primary fallopian tube carcinoma to pembrolizumab and nab-paclitaxel: A case report

RATIONALE: Primary fallopian tube carcinoma (PFTC) is an extremely rare but invasive malignancy with a dismal prognosis. Very few data exist on the salvage treatment for patients with PFTC. Here we report a case showing an impressive response to immunotherapy combined with chemotherapy, which have n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jian, Chen, Zhi-peng, Zhu, Hui-ping, Zhang, Yong-qin, Qian, Xiao-lan, Zhang, Min, Ni, Chen, Zuo, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360280/ https://www.ncbi.nlm.nih.gov/pubmed/32664168 http://dx.doi.org/10.1097/MD.0000000000021203

Ejemplares similares

Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report
por: Liang, Jin-Yan, et al.
Publicado: (2017)

Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
por: Nakano, Shintaro, et al.
Publicado: (2020)

Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma
por: Neuzillet, Cindy, et al.
Publicado: (2016)

Solvent-based paclitaxel or nab-paclitaxel for heavily treated relapsed/refractory small cell lung cancer: Retrospective single-institution observational study
por: Sugiyama, Keiji, et al.
Publicado: (2019)

Durable response of tislelizumab plus cisplatin, nab-paclitaxel followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A case report
por: Tang, Haifeng, et al.
Publicado: (2023)

A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer
por: Fukahori, Masaru, et al.
Publicado: (2021)

A rapid response of lung squamous cell carcinoma following treatment with sintilimab combined with recombinant humane endostatin injection and nab-paclitaxel in an elderly patient: A case report
por: Fang, Yueyu, et al.
Publicado: (2021)

Immunotherapy-related pneumonitis and bacterial pneumonia after the successful treatment of metastatic malignant melanoma with pembrolizumab: A case report
por: Ma, Qin, et al.
Publicado: (2021)

Pembrolizumab versus paclitaxel for previously treated, advanced gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized clinical trials
por: Swed, Sarya, et al.
Publicado: (2022)

Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab: A case report
por: Misir Krpan, Ana, et al.
Publicado: (2020)

Cytokine release syndrome induced by pembrolizumab: A case report
por: Zhang, Xinyu, et al.
Publicado: (2022)

Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis: A case report
por: Yang, Min Joo, et al.
Publicado: (2021)

Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review
por: Tan, Sirui, et al.
Publicado: (2022)

Treating the primary in low burden metastatic prostate cancer: Where do we stand?
por: Luo, Hua-Chun, et al.
Publicado: (2020)

A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)

The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer: A PRISMA Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Liu, Huan, et al.
Publicado: (2014)

Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer: A retrospective observational study
por: Oi, Hajime, et al.
Publicado: (2022)

Irreversible electroporation in primary and metastatic hepatic malignancies: A review
por: Lyu, Tianchu, et al.
Publicado: (2017)

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
por: Blais, Normand, et al.
Publicado: (2014)

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
por: De Luca, Rossella, et al.
Publicado: (2018)

Bilateral Primary Carcinoma of the Fallopian Tubes
por: Naidu, V. R., et al.
Publicado: (1944)

Primary hydatic cyst of the fallopian tube
por: Ben Ismail, Imen, et al.
Publicado: (2020)

Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case report
por: Abdou, Yara, et al.
Publicado: (2019)

Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature
por: Song, Jin-cheng, et al.
Publicado: (2017)

Paraganglioma of the Fallopian Tube Presenting as Isolated Fallopian Tube Torsion
por: Takeda, Akihiro, et al.
Publicado: (2022)

Efficacy of albumin-bound paclitaxel combined with nedaplatin in neoadjuvant therapy for esophageal squamous cell carcinoma: A single-center retrospective observational study
por: Chen, Jiakuan, et al.
Publicado: (2023)

Primary acinic cell carcinoma of the trachea: A case report and literature review
por: Yang, Mai-Qing, et al.
Publicado: (2023)

Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials
por: Liu, Yun, et al.
Publicado: (2017)

Erratum: Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
Publicado: (2014)

Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
por: Han, Sung Yong, et al.
Publicado: (2020)

Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report
por: Wang, Yong, et al.
Publicado: (2020)

A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report
por: Hamada, Kazuyuki, et al.
Publicado: (2022)

A lung squamous cell carcinoma-associated membranous nephropathy patient free of tumor and membranous nephropathy after the treatment of surgery and radiochemotherapy following pembrolizumab: A rare case report
por: Chen, Feifei, et al.
Publicado: (2023)

Platinum-doublet chemotherapy followed by pembrolizumab therapy for lung cancer with lymphangitis carcinomatosa mimicking interstitial pneumonitis: A case report
por: Yamasaki, Masahiro, et al.
Publicado: (2019)

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
por: Liao, John B, et al.
Publicado: (2021)

Prognostic factors of primary fallopian tube carcinoma
por: Akkaya, Emrah, et al.
Publicado: (2018)

Neoadjuvant chemotherapy with paclitaxel plus cisplatin before radical surgery for locally advanced cervical cancer during pregnancy: A case series and literature review
por: Huang, Huiqiong, et al.
Publicado: (2021)

Duplication of the fallopian tube
por: R, Narayanan, et al.
Publicado: (2008)

Diseases of the Fallopian Tubes
Publicado: (1885)

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer
por: Sun, Si, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9f72clihuvdb1vsdqoa6v757db